← SynDRA
CP-724714
SynDRA canonical compound SYN0018485 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | ERBB2 |
|---|
| Mechanism of action | EGFR inhibitor | protein tyrosine kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- ERBB2 INHIBITOR
- Receptor protein-tyrosine kinase erbB-2 inhibitor
- EGFR INHIBITOR
- tyrosine kinase inhibitor
Cross-references
Synonyms
- CP 724714
- CP-724,714
- CP724714
- CP724,714, CP-724,714
- 2-Methoxy-N-(3-(4-((3-methyl-4-((6-methyl-3-pyridinyl)oxy)phenyl)amino)-6-quinazolinyl)-2-propenyl)acetamide
- 2-Methoxy-N-[(2E)-3-[4-[[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]phenyl]amino]-6-quinazolinyl]-2-propen-1-yl]acetamide
- CP 724,714
- I05QZ0S4V3
- CHEBI:167658
- RefChem:1082252
- DTXCID701510261
- (E/Z)-CP-724714
- MFCD15144738
- UNII-I05QZ0S4V3
- SCHEMBL95109
- MLS006011185
- GTPL7883
- orb1303306
- SCHEMBL29561705
- SCHEMBL30450143
- BDBM31340
- CHEBI:91331
- cid_9874913
- LLVZBTWPGQVVLW-SNAWJCMRSA-N
- GLXC-07054
- EX-A2355
- NSC780042
- NSC800078
- s1167
- AKOS005146427
- CCG-269443
- CS-W009630
- EBC-220082
- EX-8511
- HY-W008914
- NSC-780042
- NSC-800078
- SDCCGSBI-0654351.P001
- NCGC00263101-04
Look up CP-724714 in the interactive SynDRA portal →